Evidence map›Paper›PMID 32802963›Full record

ArticleWellcome open research2020

Protocol: Leveraging a demographic and health surveillance system for Covid-19 Surveillance in rural KwaZulu-Natal.

Mark J Siedner, Guy Harling, Anne Derache, Theresa Smit, Thandeka Khoza, Resign Gunda, Thobeka Mngomezulu, Dickman Gareta, Nomathamsanqa Majozi, Eugene Ehlers and 13 more

Open access · goldAbstract read
In one paragraph

Article in Wellcome open research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. The impact of COVID-19 on TB: a review of the data.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2021
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 7 institutions in 4 countries.

Mark J SiednerAfrica Health Research Institute, Durban, KwaZulu-Natal, South Africa.
Guy HarlingAfrica Health Research Institute, Durban, KwaZulu-Natal, South Africa.ORCID https://orcid.org/0000-0001-6604-491X
Anne DeracheAfrica Health Research Institute, Durban, KwaZulu-Natal, South Africa.
Theresa SmitAfrica Health Research Institute, Durban, KwaZulu-Natal, South Africa.
Thandeka KhozaAfrica Health Research Institute, Durban, KwaZulu-Natal, South Africa.
Resign GundaAfrica Health Research Institute, Durban, KwaZulu-Natal, South Africa.ORCID https://orcid.org/0000-0003-1404-9879
Thobeka MngomezuluAfrica Health Research Institute, Durban, KwaZulu-Natal, South Africa.
Dickman GaretaAfrica Health Research Institute, Durban, KwaZulu-Natal, South Africa.
Nomathamsanqa MajoziAfrica Health Research Institute, Durban, KwaZulu-Natal, South Africa.
Eugene EhlersAfrica Health Research Institute, Durban, KwaZulu-Natal, South Africa.
Jaco DreyerAfrica Health Research Institute, Durban, KwaZulu-Natal, South Africa.ORCID https://orcid.org/0000-0002-9966-5744
Siyabonga NxumaloAfrica Health Research Institute, Durban, KwaZulu-Natal, South Africa.
Njabulo DayiAfrica Health Research Institute, Durban, KwaZulu-Natal, South Africa.
Gregory Ording-JespersonAfrica Health Research Institute, Durban, KwaZulu-Natal, South Africa.
Nothando NgwenyaAfrica Health Research Institute, Durban, KwaZulu-Natal, South Africa.
Emily WongAfrica Health Research Institute, Durban, KwaZulu-Natal, South Africa.
Collins IwujiAfrica Health Research Institute, Durban, KwaZulu-Natal, South Africa.ORCID https://orcid.org/0000-0003-2045-1717
Maryam ShahmaneshAfrica Health Research Institute, Durban, KwaZulu-Natal, South Africa.
Janet SeeleyAfrica Health Research Institute, Durban, KwaZulu-Natal, South Africa.ORCID https://orcid.org/0000-0002-0583-5272
Tulio De OliveiraKwaZulu-Natal Research Innovation and Sequencing Platform (KRISP)), School of Laboratory Medicine and Medical Sciences, University of KwaZulu Natal, Durban, KwaZulu-Natal, South Africa.
Thumbi Ndung'uAfrica Health Research Institute, Durban, KwaZulu-Natal, South Africa.
Willem HanekomAfrica Health Research Institute, Durban, KwaZulu-Natal, South Africa.
Kobus HerbstAfrica Health Research Institute, Durban, KwaZulu-Natal, South Africa.
Africa Health Research Institute · ZAHarvard University · USBrighton and Sussex Medical School · GBCentre for the AIDS Programme of Research in South Africa · ZALondon School of Hygiene & Tropical Medicine · GBSouth African Medical Research Council · ZAUniversity of Washington · US

Funding

H3ABioNet: informatics solutions for H3AfricaU24HG006941 · NHGRI · UNIVERSITY OF CAPE TOWN · PI MULDER, NICOLA · 2017 to 2021
$12.9M
Quality of Life and Aging with HIV in Rural UgandaR01AG059504 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI SIEDNER, MARK J · 2019 to 2023
$3.4M
Resistance testing versus adherence support for management of patients with virologic failure on first-line antiretroviral therapy in sub-Saharan Africa: An open-label randomized controlled trialR01AI124718 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MUYINDIKE, WINNIE, SIEDNER, MARK J · 2016 to 2020
$3.0M
Maximizing combination HIV prevention, uptake and retention by adolescent girls and young womenR01MH114560 · NIMH · KWAZULU-NATAL RESEARCH INSTITUTE TB-HIV · PI SHAHMANESH, MARYAM · 2017 to 2023
$2.0M
Studies of Mucosal Associated Invariant T (MAIT) cells in people with HIV, TB and HIV/TB co-infection in South AfricaK08AI118538 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI WONG, EMILY BETH · 2015 to 2019
$950k
NHGRI NIH HHS U24 HG006941NIAID NIH HHS K08 AI118538NIAID NIH HHS R01 AI124718NIA NIH HHS R01 AG059504NIMH NIH HHS R01 MH114560Wellcome Trust
6 · The paper itself

Abstract

A coordinated system of disease surveillance will be critical to effectively control the coronavirus disease 2019 (Covid-19) pandemic. Such systems enable rapid detection and mapping of epidemics and inform allocation of scarce prevention and intervention resources. Although many lower- and middle-income settings lack infrastructure for optimal disease surveillance, health and demographic surveillance systems (HDSS) provide a unique opportunity for epidemic monitoring. This protocol describes a surveillance program at the Africa Health Research Institute's Population Intervention Platform site in northern KwaZulu-Natal. The program leverages a longstanding HDSS in a rural, resource-limited setting with very high prevalence of HIV and tuberculosis to perform Covid-19 surveillance. Our primary aims include: describing the epidemiology of the Covid-19 epidemic in rural KwaZulu-Natal; determining the impact of the Covid-19 outbreak and non-pharmaceutical control interventions (NPI) on behaviour and wellbeing; determining the impact of HIV and tuberculosis on Covid-19 susceptibility; and using collected data to support the local public-sector health response. The program involves telephone-based interviews with over 20,000 households every four months, plus a sub-study calling 750 households every two weeks. Each call asks a household representative how the epidemic and NPI are affecting the household and conducts a Covid-19 risk screen for all resident members. Any individuals screening positive are invited to a clinical screen, potential test and referral to necessary care - conducted in-person near their home following careful risk minimization procedures. In this protocol we report the details of our cohort design, questionnaires, data and reporting structures, and standard operating procedures in hopes that our project can inform similar efforts elsewhere.

Indexed as

Covid-19Health and Demographic Surveillance SystemScreeningSouth AfricaSurveillance

Identifiers

PMID32802963
PMCPMC7424917
OpenAlexW3029120778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.